Cleared Traditional

K092905 - AUTOSTART BURETTE

K092905 is an FDA 510(k) clearance for AUTOSTART BURETTE, manufactured by Analytica Pty, Ltd.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 164-day FDA review.

K092905 · Analytica Pty, Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2010
Decision
164d
Days
Class 2
Risk

K092905 is an FDA 510(k) clearance for the AUTOSTART BURETTE. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Analytica Pty, Ltd. (Stillwater, US). The FDA issued a Cleared decision on March 4, 2010 after a review of 164 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Analytica Pty, Ltd. devices

FDA 510(k) Submission Details - K092905

510(k) Number K092905 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 21, 2009
Decision Date March 04, 2010
Days to Decision 164 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
35d slower than avg
Panel avg: 129d · This submission: 164d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 653
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K092905.
NEXUS PRESSURE RATED EXTENSION SETS
K092382 · Nexus Medical, LLC · Apr 2010
NEXUS INTRAVASCULAR TUBING SETS-PRE-PIERCED
K092930 · Nexus Medical, LLC · Mar 2010
AMSINO I.V. ADMINISTRATION SET, AMSAFE3 I.V ADMINISTRATION SET, EXTENSION SETS
K093773 · Amsino International, Inc. · Mar 2010
NEXUS INJECTION SITE, MODEL NIS-8
K092527 · Nexus Medical, LLC · Feb 2010
A6 LUER ACCESS DEVICE
K083723 · B.Braun Medical, Inc. · Jun 2009
INTRAVENOUS POWER INJECTOR EXTENSION SET
K090134 · C.R. Bard, Inc. · Apr 2009